| Abschluss eines nicht-exklusiven Rabattvertrages gemäß §§ 130a Abs. 8 und 130c Abs. 1 SGB V zwischen |
Gewinner
|
awarded |
01.04.2026 |
- |
1,00 EUR |
| Diphterie-Tetanus-Pertussis, Fertigspritze St | Hepatitis-A-Adsorbat-Impfstoff (HDC) 1.440 E. in 1 m |
Gewinner
|
awarded |
13.03.2026 |
- |
- |
| Diphterie-Tetanus-Pertussis, Fertigspritze St | Hepatitis-A-Adsorbat-Impfstoff (HDC) 1.440 E. in 1 m |
Gewinner
|
awarded |
13.03.2026 |
- |
- |
| Hepatitis-A 720 E., Hepatitis-B 0.02 mg Fertigspritze St a 1 ml |
Gewinner
|
awarded |
13.03.2026 |
- |
- |
| Hepatitis-A-Adsorbat-Impfstoff (HDC) 720 E. in 0.5 ml Lsg. Injektionssuspension Depot St a 0.5 ml | |
Gewinner
|
awarded |
03.03.2026 |
- |
- |
| Fluticason furoat 100,0 μg, Umeclidinium-Kation 62,5 μg, Vilanterol 25,0 μg Inhalationspulver St | M |
Gewinner
|
awarded |
03.03.2026 |
- |
- |
| Fluticason furoat 100,0 μg, Umeclidinium-Kation 62,5 μg, Vilanterol 25,0 μg Inhalationspulver St | M |
Gewinner
|
awarded |
03.03.2026 |
- |
- |
| Fluticason furoat 100,0 μg, Umeclidinium-Kation 62,5 μg, Vilanterol 25,0 μg Inhalationspulver St | M |
Gewinner
|
awarded |
03.03.2026 |
- |
- |
| Fluticason furoat 100,0 μg, Umeclidinium-Kation 62,5 μg, Vilanterol 25,0 μg Inhalationspulver St | M |
Gewinner
|
awarded |
03.03.2026 |
- |
- |
| Fluticason furoat 100,0 μg, Umeclidinium-Kation 62,5 μg, Vilanterol 25,0 μg Inhalationspulver St | M |
Gewinner
|
awarded |
03.03.2026 |
- |
- |
| Hepatitis-A-Adsorbat-Impfstoff (HDC) 720 E. in 0.5 ml Lsg. Injektionssuspension Depot St a 0.5 ml | |
Gewinner
|
awarded |
03.03.2026 |
- |
- |
| Fluticason furoat 100,0 μg, Umeclidinium-Kation 62,5 μg, Vilanterol 25,0 μg Inhalationspulver St | M |
Gewinner
|
awarded |
03.03.2026 |
- |
- |
| Fluticason furoat 100,0 μg, Umeclidinium-Kation 62,5 μg, Vilanterol 25,0 μg Inhalationspulver St | M |
Gewinner
|
awarded |
03.03.2026 |
- |
- |
| Fluticason furoat 100,0 μg, Umeclidinium-Kation 62,5 μg, Vilanterol 25,0 μg Inhalationspulver St | M |
Gewinner
|
awarded |
03.03.2026 |
- |
- |
| Fluticason furoat 100,0 μg, Umeclidinium-Kation 62,5 μg, Vilanterol 25,0 μg Inhalationspulver St | M |
Gewinner
|
awarded |
03.03.2026 |
- |
- |
| Atovaquon 750 mg in 5 ml Saft Suspension zum Einnehmen St a 226 ml |
Gewinner
|
awarded |
03.03.2026 |
- |
- |
| Fluticason furoat 100,0 μg, Umeclidinium-Kation 62,5 μg, Vilanterol 25,0 μg Inhalationspulver St | M |
Gewinner
|
awarded |
03.03.2026 |
- |
- |
| Hepatitis-A-Adsorbat-Impfstoff (HDC) 720 E. in 0.5 ml Lsg. Injektionssuspension Depot St a 0.5 ml | |
Gewinner
|
awarded |
03.03.2026 |
- |
- |
| Hepatitis-A-Adsorbat-Impfstoff (HDC) 720 E. in 0.5 ml Lsg. Injektionssuspension Depot St a 0.5 ml | |
Gewinner
|
awarded |
03.03.2026 |
- |
- |
| Hepatitis-A-Adsorbat-Impfstoff (HDC) 720 E. in 0.5 ml Lsg. Injektionssuspension Depot St a 0.5 ml | |
Gewinner
|
awarded |
03.03.2026 |
- |
- |